Regulation of gene expression of the 25-Hydroxyvitamin D 1α-Hydroxylase (CYP27B1) promoter : study of a transgenic mouse model. by Hendrix, Ivanka
Regulation of Gene Expression of the 

25-Hydroxyvitamin D la-Hydroxylase (CYP27BI) Promoter: 

Study of A Transgenic Mouse Model 

Ivanka Hendrix 
School of Molecular and Biomedical Science 





A thesis submitted for the degree of 

Doctor of Philosophy 
to 


















Presentations Arising xiv 

List of tables XXI 

Awards Arising xv 

List of figures XVI 

1 Chapter 1: Activation of 25-Hydroxyvitamin D 1 

1.1 Introduction 1 

1.2 Vitamin D Metabolic Pathway 2 

1.2.1 Vitamin D 25-Hydroxylase 2 

1.2.2 25-Hydroxyvitamin D 1 a-Hydroxylase 5 

1.2.3 25-Hydroxyvitamin D 24-Hydroxylase 6 

1.3 Actions of 1,25D 8 

1.3.1 Calcium Homeostasis 8 

1.3.2 Reproduction 12 

1.3.3 Immune System 13 

1.3.4 Cellular Growth and Differentiation 14 

1.4 Renal and Non-Renal Expression of the CYP27B1 Gene 15 







1.5.1 Parathyroid Hormone 	 17 
1.5.2 1,25D 	 18 
1.5.3 Growth and Development 
1.5.4 Calcium 	 20 
1.5.5 Lipopolysaccharide 	 20 
1.5.6 Others 	 21 
1.6 Non-Renal Sites of 1,25D Synthesis and Action 	 22 


























1.7 	 Conclusion 
1.8 	 General Aims of this Thesis 
2 	 Chapter 2: Regulation of Expression of the Human CYP27B1 Gene Promoter: 36 
Establishment ofa Transgenic Mouse Model 
2.1 	 Introduction 36 





2.2.1 Materials 38 

2.2.1.1 Chemicals 38 

2.2.1.2 Buffer Solutions 38 

2.2.1.3 Loading Buffer for Electrophoresis 38 

2.2.1.4 Formamide 39 

2.2.2 Animals 39 

2.2.2.1 Housing and Diet 
2.2.2.2 Record Keeping 
2.2.3 Preparation of DNA Fragment for Microinjection 40 

2.2.3.1 Synthesis of pGL3-CYP27B1-Luciferase Vector 40 

2.2.3.2 Isolation of DNA Fragment for Microinjection 40 

2.2.3.3 Purification of DNA Fragment for Microinjection 43 

2.2.4 Transgenesis 44 

2.2.4.1 Superovulation of Female Mice 44 

2.2.4.2 Embryo Retrieval 45 

2.2.4.3 Pro-Nuclear Injection 46 

2.2.4.4 Embryo Transfer 46 

2.2.5 Genotyping of Transgenic Offspring 46 

2.2.5.1 DNA Extraction from Tail Biopsies 46 

2.2.5.2 Quantification of Genomic Mouse DNA 47 

2.2.5.3 Preparation of a DNA Luciferase Probe 
2.2.5.4 Genotyping of Transgenic Founders by Southern Blot Analysis 
2.2.5.4.1 Gel Electrophoresis and Nylon Membrane Transfer 49 

2.2.5.4.2 Pre-Hybridization of the Nylon Membrane 50 










2.2.5.4.4 	 Washing of the Nylon Membrane and Visualization of the Radioactive Signal 
2.2.5.5 Genotyping of Subsequent Transgenic Offspring by PCR 
2.2.6 Analysis of Reporter Gene Expression 	 54 

2.2.6.1 	 Tissue Collection 
2.2.6.2 	 Preparation of Tissue Homogenates 
2.2.6.3 Measurement of Luciferase Activity 
2.2.6.4 	 Measurement of Protein Content 
2.2.7 Characterization of the Transgenic Lines 	 57 

2.3 Results 	 58 

2.3.1 The Transgenic Construct Used in this Project 	 58 

2.3.2 Transgenic Founders 	 60 

2.3.3 Inheritance Pattern of the Transgenic Construct 	 61 

2.3.4 Tissue-Specific Reporter Gene Expression in Line 3042 	 63 

2.3.5 Tissue-Specific Reporter Gene Expression in Line 3039 	 63 

2.3.6 	 Tissue-Specific Reporter Gene Expression in Line 2992 66 

2.4 	 Discussion 66 





3.1 	 Introduction 72 

Materials and Methods 
3.2.1 Animals 	 74 











3.2.1.3 Diet 75 

3.2.1.4 Semi-Synthetic Diet 75 

3.2.1.5 Blood Sample Collection 78 

3.2.1.6 Record Keeping 78 

3.2.2 Blood Biochemistry 79 

3.2.2.1 Serum 25-Hydroxyvitamin D3 
3.2.3 Statistical Analysis 
3.2.3.1 One-Way Analysis of Variance 
3.2.3.2 Tukey's Post-Hoc Test 79 

3.2.4 Chemicals 80 

3.2.5 Effect of Aging 80 

3.2.6 Effect of Dietary Calcium and Vitamin D Manipulation 80 

3.2.7 Effect of Lipopolysaccharide Administration 81 

3.2.8 Enzymatic Luciferase Activity and Protein Assays 82 

3.2.9 Analysis of Endogenous Gene Expression 83 

3.2.9.1 Total RNA Extraction 83 

3.2.9.2 Quantification of Total RNA 84 

3.2.9.3 First-Strand DNA Synthesis 84 

3.2.9.4 Quantitative Real-Time Reverse Transcriptase-Polymerase Chain Reaction 85 





3.3.1 Serum Biochemistry 89 

3.3.2 Effect of Aging on Gene Expression in the Kidney 90 

3.3.3 Effect of Dietary Calcium on Gene Expression in the Kidney 90 





3.3.5 	 Effect of Lipopolysaccharide on Gene Expression in the Kidney 
3.3.6 	 Immunohistochemistry 
3.4 	 Discussion 95 
4 	 Chapter 4: Effects of Aging, Lipopolysaccharide Administration and Dietary 104 
Calcium and Vitamin D on Reporter Gene Expression in Extra-Renal Tissues 
4.1 	 Introduction 104 






















Blood Sample Collection 
Record Keeping 
Blood Biochemistry 
Serum 25-Hydroxyvitamin D3 
Statistical Analysis 
One-Way Analysis of Variance 
Tukey's Post-Hoc Test 
Chemicals 
Effect of Aging 
Effect of Dietary Calcium and Vitamin D Manipulation 



















4.2.8 	 Enzymatic Luciferase Activity and Protein Assays 109 

4.2.9 	 Analysis of Endogenous Gene Expression 110 

4.2.9.1 	 Total RNA Extraction 110 

4.2.9.2 	 Quantification of Total RNA 110 

4.2.9.3 	 First-Strand DNA Synthesis 110 

4.2.9.4 	 Quantitative Real-Time Reverse Transcriptase-Polymerase Chain Reaction 110 

4.2.10 	 Immunohistochemistry III 

4.3 	 Results 111 

4.3.1 	 Effect of Aging on Reporter Gene Expression in Non-Renal Tissues 111 

4.3.2 	 Effect of Dietary Calcium on Reporter Gene Expression in Non-Renal Tissues 122 













5 Chapter 5: Summary and Conclusions 	 143 

Bibliography 	 149 

Abstract 
The enzyme 25-hydroxyvitamin D la-hydroxylase or CYP27Bl is the key 
enzyme in the two-step activation process by which vitamin D is converted to its 
biologically active form 1,25-dihydroxyvitamin D (1,25D). The actions of a number 
of regulators on the renal CYP27B 1 enzyme activity have been recognized for some 
years, although the underlying molecular mechanisms remain largely unknown and 
the DNA regions involved in the in vivo regulation of gene expression by these factors 
have not been delineated as yet. 
In order to identify the regulatory regions through which these factors control 
CYP27B 1 expression in the kidney in vivo and to study the spatial and temporal 
expression of the CYP27B 1 gene during development, a transgenic mouse model was 
established. This model was developed using pro-nuclear injection of a DNA 
construct containing the firefly luciferase reporter gene under the control of the 1541 
bp region of the human CYP27B 1 promoter. 
Following pro-nuclear injection, three transgenic founders were obtained and 
bred to establish three independent transgenic lines. In all three lines, a very similar 
expression pattern of the luciferase reporter gene was detected. High levels of 
luciferase activity were detected in the kidney, brain, testis, skin and bone. Lower 
levels of luciferase activity were detected in heart, lung, liver, distal small intestine, 
skeletal muscle and spleen extracts. No reporter gene expression could be detected in 
the proximal small intestine. 
This animal model was used to identify the ability of the 1541 bp promoter 
region of the CYP27B 1 gene to respond in the kidney to a number of physiological 
challenges including dietary calcium, vitamin D and the immunomodulator LPS. In 
addition, the temporal expression of the reporter gene was studied by sacrificing 
animals at 6 different time points (2, 4, 6, 8, 12 and 64 weeks of age). The 
functionality of the CYP27B 1 promoter was verified by comparing the regulation of 
the expression of the reporter gene with that of the endogenous CYP27B 1 gene. The 
expression of endogenous CYP27B1 mRNA levels was therefore determined using 
Real-Time RT-PCR. 
The expression of the reporter gene and the endogenous CYP27B 1 mRNA 
levels in the kidney were increased during early development (2 week old animals) 
and fell with increasing age. Reporter gene expression and CYP27BI mRNA levels 
were down-regulated in response to increasing amounts of dietary calcium in a dose­
dependent manner. Vitamin D-deficiency resulted in an increase in both the reporter 
gene and CYP27B 1 expression. However, the increase in CYP27B 1 mRNA levels 
was substantially higher than the increase in reporter gene expression, suggesting that 
other regulatory elements are required to maximize the effect of vitamin D-deficiency. 
LPS administration did not affect the expression of either luciferase or the 
endogenous CYP27B1 gene in the kidney. 
Immunohistochemistry was used to identify the cell-specific location of the 
luciferase and the endogenous CYP27B 1 protein in the kidney in kidney sections of 
vitamin D-deficient animals. Both luciferase protein and the endogenous CYP27B1 
protein were identified in the proximal tubular cells of the kidney. 
The regulation of the expression of the reporter gene was also studied in the 
transgenic mouse model in a number of extra-renal tissues that have been shown to 
express CYP27Bl and to be responsive to 1,25D. These tissues include heart, liver, 
lung, femora, bone marrow, skeletal muscle, testis, skin, brain, spleen and proximal 
and distal small intestine. Although in most tissues, the expression of luciferase was 
highest in the 2 week old animals and fell with increasing age, in the testis, the 
expression levels were low in the developing animals and increased with increasing 
age. 
No physiological significant effects were detected in any of the extra-renal 
tissues examined in response to dietary calcium and vitamin D, suggesting that these 
factors control CYP27Bl expression in a kidney-specific manner. In addition, no 
physiologically significant effect of the LPS administration could be detected in these 
tissues. 
Future studies employing transgenic animals which express transgenic 
constructs containing both the CYP27Bl promoter and upstream and/or intronic 
sequences are required to identify the factors that regulate CYP27Bl expression in the 
different tissues and to delineate the DNA regulatory regions through which these 
factors exert their effects in vivo. 
